Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH): -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (115)	5/14/2003 5:38:12 PM
From: Biomaven	Read Replies (1) \| Respond to of 510

tuck, As I understand it (and I could well be wrong) CIPH's IP is in the machine itself and in any biomarkers it discovers along the way. Correlogic (I think) focuses on software for teasing out biomarkers from the mass of data produced by either CIPH's machine or something like it (like Advion's machine). In actual practice, once you have identified the particular biomarkers of interest for some disease, I assume you would use some sort of immunoassay to measure them for population screening, not a mass spec type instrument. Peter